Cargando…
Promising Novel Treatment against Keloids: Antivascular Endothelial Growth Factor Agents
Autores principales: | Abtahi-Naeini, Bahareh, Saffaei, Ali, Hadian, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830013/ https://www.ncbi.nlm.nih.gov/pubmed/31728351 http://dx.doi.org/10.4103/jrpp.JRPP_19_58 |
Ejemplares similares
-
Systematic Review of Soft-tissue Filler–associated Blindness: A Methodologic Concern Beyond Duplicated Cases
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2019) -
Gulucatime versus Glucantime: A Serious Warning on Counterfeit Medicines
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2019) -
Scalp necrotic wound and hyperinflammatory shock related to COVID‐19: Topical sucralfate as a promising topical agent
por: Pourmoghaddas, Zahra, et al.
Publicado: (2022) -
Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021) -
Intralesional Bevacizumab (Avastin(®)) as a Novel Addition to Infantile Hemangioma Management: A Medical Hypothesis
por: Pourazizi, Mohsen, et al.
Publicado: (2017)